The Epworth Sleepiness Scale (ESS) is a numerical scale developed by Murray Johns in 1991 as a subjective assessment of daytime sleepiness. 1 It has been translated and validated in many languages and widely used in clinical and research settings as an index of sleepiness associated with obstructive sleep apnea (OSA) and other conditions. It is generally accepted that a score of > 10 indicates the presence of sleepiness.
In this issue of the Journal, Campbell et al conducted a retrospective analysis of sequential ESS scores in suspected OSA patients across a diagnostic referral pathway.
2 Their study showed that the ESS scores are variable when administered sequentially within a 6-month period. Seven percent of the patients dropped from > 10 to < 10 between initial and subsequent ESS assessments while 7.8% of patients had their ESS increase from < 10 to > 10. The Campbell at al study results are non-biased as it is a retrospective study, so patients were not aware that the sequential scores would be compared. The findings from the Campbell at al study 2 remind us of the limitations of the ESS that make it inadequate as a singular tool in stratifying patients at risk for OSA. However, it can be a useful adjunct in the assessment of OSA patients when used in conjunction with a thorough history, clinical exam and other validated OSA screening tools, which incorporate symptoms, signs and risk factors for OSA. Going forward, we as sleep specialists need to de-emphasize the role of ESS in OSA assessment and educate our peers and health care decision makers that irrespective of OSA severity, not all OSA patients are sleepy and even when present, sleepiness may manifest in a variety of ways outside of those delineated in the ESS. As emphasized in an editorial in the Journal from several years ago, 10 the ESS should not be used by itself to determine eligibility for a sleep study.
